<SEC-DOCUMENT>0001069530-22-000051.txt : 20221027
<SEC-HEADER>0001069530-22-000051.hdr.sgml : 20221027
<ACCEPTANCE-DATETIME>20221027160323
ACCESSION NUMBER:		0001069530-22-000051
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20221013
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221027
DATE AS OF CHANGE:		20221027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CASSAVA SCIENCES INC
		CENTRAL INDEX KEY:			0001069530
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911911336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29959
		FILM NUMBER:		221337296

	BUSINESS ADDRESS:	
		STREET 1:		7801 N CAPITAL OF TEXAS HIGHWAY
		STREET 2:		SUITE 260
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78731
		BUSINESS PHONE:		512-501-2444

	MAIL ADDRESS:	
		STREET 1:		7801 N CAPITAL OF TEXAS HIGHWAY
		STREET 2:		SUITE 260
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78731

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PAIN THERAPEUTICS INC
		DATE OF NAME CHANGE:	20000309
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sava-20221013x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Inline XBRL document created by Certent Disclosure Management 1.0.0.0-->
<!--Created on: 10/27/2022 19:59:46 PM-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:sava="http://www.cassavasciences.com/20221013" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <head>
    <title>sava-20221013x8k</title>
    <meta http-equiv="Content-Type" content="text/html" /></head>
  <body xml:lang="en-US">
    <div style="display:none"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="ct-nonNumeric-2bf1c9cf-e289-4017-a12f-218ac2648c7d" contextRef="Duration_10_13_2022_To_10_13_2022" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="ct-nonNumeric-084f69ef-5155-4688-8ef5-0e7ddda6073b" contextRef="Duration_10_13_2022_To_10_13_2022">0001069530</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="sava-20221013.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_10_13_2022_To_10_13_2022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-13</xbrli:startDate><xbrli:endDate>2022-10-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
    <div class="headerContainer"></div>
    <div><div style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0.5pt;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 18pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 3pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 18pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">UNITED STATES</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 18pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 18pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">SECURITIES AND EXCHANGE COMMISSION</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Washington, D.C. 20549</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 10pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">___________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 18pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 18pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">FORM </span><ix:nonNumeric name="dei:DocumentType" id="ct-nonNumeric-92098f62-58de-461d-8eed-356ab2b4b4d8" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 18pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">8-K</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 10pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">___________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 13.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 13.5pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CURRENT REPORT</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Pursuant to Section&#160;13 or 15(d) of the</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Securities Exchange Act of 1934</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Date of Report (Date of earliest event reported) </span><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="ct-nonNumeric-7d1eadf0-91ec-4165-a1cb-dff2c9271858" contextRef="Duration_10_13_2022_To_10_13_2022" format="ixt:datemonthdayyearen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">October 13, 2022</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 10pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">___________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 24pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><ix:nonNumeric name="dei:EntityRegistrantName" id="ct-nonNumeric-a16cf31e-2476-4e50-9498-438c32fa6312" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: Sansation;font-size: 24pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cassava Sciences, Inc.</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Exact name of registrant as specified in its charter)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 10pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">___________________</span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 29.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 39.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 28.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 29.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="ct-nonNumeric-ad8e6550-3cf9-4f72-ac32-d51f798759ac" contextRef="Duration_10_13_2022_To_10_13_2022" format="ixt-sec:stateprovnameen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Delaware</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 39.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityFileNumber" id="ct-nonNumeric-888b5ebe-a911-4bc5-9ee3-f4a6dd397977" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">000-29959</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 28.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="ct-nonNumeric-0360d3a1-16e7-48a5-abb3-a0debda651d9" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">91-1911336</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 29.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(State or other jurisdiction</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">of incorporation)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 39.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Commission</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">File Number)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 28.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(I.R.S. Employer</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Identification Number)</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="ct-nonNumeric-d0062e3f-5717-4f60-8014-fc7907f8e559" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">6801 N Capital of Texas Highway</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">, </span><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="ct-nonNumeric-db83786a-551b-421a-af34-9aa00de6fb6f" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Building 1; Suite 300</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="ct-nonNumeric-d234f2d2-6623-4ebf-9fc3-d8626ca19e14" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Austin</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">, </span><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="ct-nonNumeric-6c95a691-db9a-4408-a7b5-6040122f438b" contextRef="Duration_10_13_2022_To_10_13_2022" format="ixt-sec:stateprovnameen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Texas</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="ct-nonNumeric-9c845b64-2e42-4802-9941-2ae749577784" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">78731</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 7.5pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Address of principal executive offices, including zip code)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(</span><ix:nonNumeric name="dei:CityAreaCode" id="ct-nonNumeric-ab75a49c-8bd6-4523-a8ac-09fbdf22b278" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">512</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">) </span><ix:nonNumeric name="dei:LocalPhoneNumber" id="ct-nonNumeric-5e04066d-4666-464b-b5a7-2862990eb1cb" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">501-2444</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 7.5pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Registrant&#8217;s telephone number, including area code)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 7.5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 7.5pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Former name or former address, if changed since last report.)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 10pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">___________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 19.45pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 19.45pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><ix:nonNumeric name="dei:WrittenCommunications" id="ct-nonNumeric-5c2b30d5-6bd1-437d-b738-35b0dbf12b26" contextRef="Duration_10_13_2022_To_10_13_2022" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61608;</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ThereWritten communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 19.45pt;"><p dir="ltr" style="text-align:left; font-family: Wingdings;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><ix:nonNumeric name="dei:SolicitingMaterial" id="ct-nonNumeric-4feb3c65-ae97-48dd-a9a3-a670e525ba61" contextRef="Duration_10_13_2022_To_10_13_2022" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61608;</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 19.45pt;"><p dir="ltr" style="text-align:left; font-family: Wingdings;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="ct-nonNumeric-5cad1bda-5d40-4954-802c-d55f7ea45dfa" contextRef="Duration_10_13_2022_To_10_13_2022" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61608;</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 19.45pt;"><p dir="ltr" style="text-align:left; font-family: Wingdings;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="ct-nonNumeric-91b10ab2-476b-4803-bb40-3f180f7ff6dc" contextRef="Duration_10_13_2022_To_10_13_2022" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61608;</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 6pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 6pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Securities registered pursuant to Section 12(b) of the Act:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 38.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 45.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 38.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Title of each class</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Trading</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Symbol(s)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 45.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Name of each exchange on which registered</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 205.2pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="ct-nonNumeric-4317c70c-317d-4ea1-b8a8-8476edb45cc8" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Common Stock, $0.001 par value</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 5.4pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 81pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="ct-nonNumeric-3e30f0ff-5e41-48a7-a079-f6aabf4f114a" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SAVA</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 5.4pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 243pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="ct-nonNumeric-35ccfbc3-7354-42df-b3b2-9716bf3f798d" contextRef="Duration_10_13_2022_To_10_13_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">NASDAQ</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Capital Market</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Emerging growth company   </span><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="ct-nonNumeric-15cd455c-da27-4757-a864-826fdd7dc075" contextRef="Duration_10_13_2022_To_10_13_2022" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61608;</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61472;&#61608;</span></p><div style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0.5pt;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 2pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 2pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 2pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 5.02.&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#65279;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On October 27, 2022, Cassava Sciences, Inc. (the &#8220;Company&#8221;) announced the appointment of R. Christopher Cook, age 58, as Senior Vice President and General Counsel, effective on or before December 1, 2022. Mr. Cook expects to start his new role with the Company shortly.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Mr. Cook </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">has over 25 years of experience working in health care, private practice and government. He joins Cassava Sciences from Alcon Inc., a publicly traded medical company, where he served as the Global Head of Litigation and Government Investigations since 2017. Prior to Alcon Inc., he was the Vice President and division General Counsel for Walmart Central America in San Jose, Costa Rica. Mr. Cook practiced law at Jones Day, a multinational law firm, for seventeen years, where he was a litigation partner in the firm&apos;s Washington, DC and Chicago offices. Before Jones Day, he served as an Assistant United States Attorney in Chicago. He holds a B.A. in English from Emory University and a Juris Doctor from Harvard Law School.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There are no family relationships</span><span id="_cp_text_1_52" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, as defined in Item 401 of Regulation S-K, between Mr. Cook&#160;and any of the Company&#8217;s directors or executive officers, and there is no arrangement or understanding between Mr. Cook&#160;and any other person pursuant to which he was&#160;</span><span id="_cp_text_1_54" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">appointed as an officer of the Company.&#160;Mr. Cook&#160;does not have any direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a) of Regulation S-K.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Pursuant to the terms of an employment agreement, executed on October 13, 2022 (the &#8220;Employment Agreement&#8221;), between the Company and Mr. Cook, the Company will pay Mr. Cook&#160;an annual base salary of $425,000 beginning on his first date of employment (the &#8220;Effective Date&#8221;). Mr. Cook is also eligible to earn a discretionary cash or equity bonus and is</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> eligible to receive other benefits applicable generally to employees.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Employment Agreement provides that on the Effective Date, the Company will grant Mr. Cook options to purchase 100,000 shares of Company common stock with a per share exercise price equal to the closing price per share of Company common stock on the Effective Date. The&#160;stock options vest monthly and equally over 48 months from the grant date, subject to Mr. Cook&#8217;s continued employment with the Company.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If Mr. Cook&#160;is terminated without cause or is subject to a &#8220;constructive dismissal&#8221;&#160;at any time following the date&#160;</span><span id="_cp_text_1_57" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">that is six (6) months following the Effective Date,&#160;he will be entitled to (i) continued payment of his base salary as then in effect for a period of three&#160;</span><span id="_cp_text_1_60" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(3) months following the date of termination and (ii) he will be entitled to continued employment benefits through COBRA premiums paid by the Company, until the earlier of three&#160;</span><span id="_cp_text_1_61" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(3) months after termination or the time that he obtains employment with another entity. If Mr. Cook&#160;is terminated&#160;without cause after a &#8220;Change in Control&#8221; (as&#160;defined in the Employment Agreement),&#160;he&#160;will be paid&#160;his&#160;regular base salary, and&#160;he&#160;will continue to receive employment benefits, for a period of&#160;twelve (12)&#160;months following&#160;his&#160;last date of employment&#160;provided he&#160;signs&#160;and does&#160;not revoke an employment separation and release agreement.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In addition, the Company has entered into an indemnification agreement with Mr. Cook on the form previously approved by the Company&#8217;s Board of Directors and entered into with the Company&#8217;s other officers.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The foregoing&#160;</span><span id="_cp_text_1_118" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">description&#160;</span><span id="_cp_text_4_119" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">of the Employment Agreement&#160;</span><span id="_cp_text_1_120" style="text-decoration: none;"></span><span id="_cp_text_1_122" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">does not purport to be complete and&#160;</span><span id="_cp_text_1_124" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">is qualified in&#160;</span><span id="_cp_text_1_126" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">its entirety by reference to the full text of the&#160;</span><span id="_cp_text_1_128" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">agreement, which&#160;</span><span id="_cp_text_1_130" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">is filed herewith as Exhibit&#160;</span><span id="_cp_text_1_131" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10.1</span><span id="_cp_text_1_132" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;and&#160;</span><span id="_cp_text_1_133" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">is incorporated herein by reference.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company&#8217;s Board of Directors has also authorized that Mr. Cook&#160;be added as a participant in the Company&#8217;s 2020 Cash Incentive Bonus Plan on the Effective Date.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 7.01. Regulation FD Disclosure.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">A copy of the Company&#8217;s press release announcing the appointment of R. Christopher Cook&#160;as the Company&#8217;s Senior Vice President and General Counsel is attached hereto&#160;as Exhibit 99.1 and is incorporated herein by reference.</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 9.01. Financial Statements and Exhibits.</span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;text-decoration: underline;">Exhibit Number</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;text-decoration: underline;">Description</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10.1</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20221013xex10_1.htm"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Employment Agreement, executed on October 13, 2022, by and between Cassava Sciences, Inc. and R. Christopher Cook</span></a></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">99.1</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20221013xex99_1.htm"><span style="white-space:pre-wrap; background: #FFFFFF;color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Press Release issued by Cassava Sciences, Inc. on October 27, 2022</span></a></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">104</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">SIGNATURE</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p><div style="padding-left: 0;text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 45.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="_Hlk8292710" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: Sansation;font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CASSAVA SCIENCES, INC.</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 45.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">a Delaware corporation</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Date:   October 27, 2022</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">By:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">/s/ ERIC J. SCHOEN</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Eric J. Schoen</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Chief Financial Officer</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>sava-20221013xex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 22.2.0.1-->
<!--Created on: 10/27/2022 2:59:54 PM-->
<html>
	<head>
		<title>
			Exhibit 101 - Offer Letter Chris Cook
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:108pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:center;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

			<font style="display: inline;font-family:Calibri;font-weight:bold;color:#C00000;">PERSONAL AND C</font><font style="display: inline;font-family:Calibri;font-weight:bold;color:#C00000;">ONFIDENTIAL</font>

		</p>

</div>
		<p style="margin:0pt 0pt 2pt;line-height:normal;text-align:center;font-family:Garamond;punctuation-wrap:hanging;font-size: 11pt">
			<a name="_Hlk525137752"></a><font style="display: inline;"><img src="sava-20221013xex10_1g001.jpg" style="width: 4.805555in; height: 1.5731in" alt="Picture 1"></font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:center;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:right;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;font-size:12pt;"></font><font style="display: inline;font-family:Calibri;font-weight:bold;font-size:12pt;">Exhibit 10.1</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">October 12, 2022</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<a name="_Hlk103954165"></a><font style="display: inline;font-family:Calibri;">Mr. </font><font style="display: inline;font-family:Calibri;">R. Christopher Cook</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">XXXXXXXX</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">XXXXXXXX</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-style:italic;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">Dear </font><font style="display: inline;font-family:Calibri;font-size:12pt;">Chris</font><font style="display: inline;font-family:Calibri;font-size:12pt;">:</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">On behalf of </font><font style="display: inline;font-family:Calibri;font-size:12pt;">the Board of Directors of </font><font style="display: inline;font-family:Calibri;font-size:12pt;">Cassava Science</font><font style="display: inline;font-family:Calibri;font-size:12pt;">s</font><font style="display: inline;font-family:Calibri;font-size:12pt;">, Inc.</font><font style="display: inline;font-family:Calibri;font-size:12pt;">, &nbsp;</font><font style="display: inline;font-family:Calibri;font-size:12pt;">(the &#x201C;Company&#x201D;) </font><font style="display: inline;font-family:Calibri;font-size:12pt;">I &nbsp;</font><font style="display: inline;font-family:Calibri;font-size:12pt;">am pleased to </font><font style="display: inline;font-family:Calibri;font-size:12pt;">extend </font><font style="display: inline;font-family:Calibri;font-size:12pt;">you </font><font style="display: inline;font-family:Calibri;font-size:12pt;">an </font><font style="display: inline;font-family:Calibri;font-size:12pt;">offer </font><font style="display: inline;font-family:Calibri;font-size:12pt;">of employment</font><font style="display: inline;font-family:Calibri;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-size:12pt;">as</font><font style="display: inline;font-family:Calibri;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-weight:bold;font-size:12pt;">Senior </font><font style="display: inline;font-family:Calibri;font-weight:bold;font-size:12pt;">VP</font><font style="display: inline;font-family:Calibri;font-weight:bold;font-size:12pt;"> and </font><font style="display: inline;font-family:Calibri;font-weight:bold;font-size:12pt;">General Counsel</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> (&#x201C;GC&#x201D;)</font><font style="display: inline;font-family:Calibri;font-size:12pt;">, an </font><font style="display: inline;font-family:Calibri;font-size:12pt;">o</font><font style="display: inline;font-family:Calibri;font-size:12pt;">fficer</font><font style="display: inline;font-family:Calibri;font-size:12pt;">-level</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> position.</font><font style="display: inline;font-family:Calibri;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-size:12pt;">This </font><font style="display: inline;font-family:Calibri;font-size:12pt;">L</font><font style="display: inline;font-family:Calibri;font-size:12pt;">etter </font><font style="display: inline;font-family:Calibri;font-size:12pt;">A</font><font style="display: inline;font-family:Calibri;font-size:12pt;">greement</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> is</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> intended </font><font style="display: inline;font-family:Calibri;font-size:12pt;">to </font><font style="display: inline;font-family:Calibri;font-size:12pt;">set </font><font style="display: inline;font-family:Calibri;font-size:12pt;">forth </font><font style="display: inline;font-family:Calibri;font-size:12pt;">the terms and conditions of your new employment</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> with the Company.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">As GC, you will report to Remi Barbier, Chairman of the Board, President &amp; CEO. During your employment with the Company, you agree to devote your full business time and your best efforts, business judgment, skill, and knowledge exclusively to the advancement of the business and interests of the Company and to the discharge of your duties and responsibilities for it, provided, however, it is agreed that you may serve on outside boards (with prior </font><font style="display: inline;font-family:Calibri;font-size:12pt;">written </font><font style="display: inline;font-family:Calibri;font-size:12pt;">notice to and </font><font style="display: inline;font-family:Calibri;font-size:12pt;">written </font><font style="display: inline;font-family:Calibri;font-size:12pt;">approval by the </font><font style="display: inline;font-family:Calibri;font-size:12pt;">CEO</font><font style="display: inline;font-family:Calibri;font-size:12pt;">), participate in charitable and civic organizations, and manage your personal investments to the extent such activities do not interfere with your duties and responsibilities to the Company.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">As GC, you will have </font><font style="display: inline;font-family:Calibri;font-size:12pt;">broad</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> duties and responsibilities that are consistent with the role of</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> the highest </font><font style="display: inline;font-family:Calibri;font-size:12pt;">legal </font><font style="display: inline;font-family:Calibri;font-size:12pt;">o</font><font style="display: inline;font-family:Calibri;font-size:12pt;">fficer</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> of </font><font style="display: inline;font-family:Calibri;font-size:12pt;">Cassava Sciences</font><font style="display: inline;font-family:Calibri;font-size:12pt;">.</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> Examples of such duties may include providing </font><font style="display: inline;font-family:Calibri;font-size:12pt;">legal</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> counsel and guidance to the </font><font style="display: inline;font-family:Calibri;font-size:12pt;">Company and its managers</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> on a variety of legal and policy matters; developing legal strategies and solutions; reviewing </font><font style="display: inline;font-family:Calibri;font-size:12pt;">contracts, </font><font style="display: inline;font-family:Calibri;font-size:12pt;">policies, procedures, regulations, bylaws and other legal documents; managing outside counsel to handle claims and litigation;</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> provid</font><font style="display: inline;font-family:Calibri;font-size:12pt;">ing</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> strategic and tactical guidance on matters related to the Company&#x2019;s affairs;</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> maintaining professional growth and development to keep abreast of latest </font><font style="display: inline;font-family:Calibri;font-size:12pt;">developments in legal </font><font style="display: inline;font-family:Calibri;font-size:12pt;">areas</font><font style="display: inline;font-family:Calibri;font-size:12pt;">; &nbsp;</font><font style="display: inline;font-family:Calibri;font-size:12pt;">and other </font><font style="display: inline;font-family:Calibri;font-size:12pt;">duties and </font><font style="display: inline;font-family:Calibri;font-size:12pt;">responsibilities</font><font style="display: inline;font-family:Calibri;font-size:12pt;">, as </font><font style="display: inline;font-family:Calibri;font-size:12pt;">assigned to you by the CEO or</font><font style="display: inline;font-family:Calibri;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-size:12pt;">by </font><font style="display: inline;font-family:Calibri;font-size:12pt;">the Company&#x2019;s Board of Director</font><font style="display: inline;font-family:Calibri;font-size:12pt;">s</font><font style="display: inline;font-family:Calibri;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">Your base salary will be</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> four hundred and twenty-five thousand dollars ($425,000)</font><font style="display: inline;font-family:Calibri;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-size:12pt;">per </font><font style="display: inline;font-family:Calibri;font-size:12pt;">calendar </font><font style="display: inline;font-family:Calibri;font-size:12pt;">year, paid bi-monthly.</font><font style="display: inline;font-family:Calibri;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-size:12pt;">Y</font><font style="display: inline;font-family:Calibri;font-size:12pt;">our </font><font style="display: inline;font-family:Calibri;font-size:12pt;">cash</font><font style="display: inline;font-family:Calibri;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-size:12pt;">compensation </font><font style="display: inline;font-family:Calibri;font-size:12pt;">is</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> subject to deduction and </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 10pt">

			<font style="display: inline;font-family:Calibri;font-size:10pt;">Page </font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;">1</font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;"> of </font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;">3</font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font>

		</p>

		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:center;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

			<font style="display: inline;font-family:Calibri;font-weight:bold;color:#C00000;">PERSONAL AND C</font><font style="display: inline;font-family:Calibri;font-weight:bold;color:#C00000;">ONFIDENTIAL</font>

		</p>

</div>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;;font-size: 12pt"><font style="display: inline;font-family:Calibri;font-size:12pt;">withholding authorized or required by applicable law. </font><font style="display: inline;font-family:Calibri;font-size:12pt;">Your base salary will be subject to review from time to time</font><font style="display: inline;font-family:Calibri;font-size:12pt;">. S</font><font style="display: inline;font-family:Calibri;font-size:12pt;">alary adjustments may be made based upon the Company&#x2019;s compensation review practices and in the Company&#x2019;s sole discretion. In addition, </font><font style="display: inline;font-family:Calibri;font-size:12pt;">from time to time </font><font style="display: inline;font-family:Calibri;font-size:12pt;">the Company may</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> grant you</font><font style="display: inline;font-family:Calibri;font-size:12pt;">, in its sole discretion, discretionary </font><font style="display: inline;font-family:Calibri;font-size:12pt;">cash </font><font style="display: inline;font-family:Calibri;font-size:12pt;">bonus amounts</font><font style="display: inline;font-family:Calibri;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">You will be granted a stock option to purchase</font><font style="display: inline;font-family:Calibri;"> one hundred thousand (100,000) </font><font style="display: inline;font-family:Calibri;">shares of Common Stock</font><font style="display: inline;font-family:Calibri;">.</font><font style="display: inline;font-family:Calibri;"> Options vest monthly and equally over 48 months. </font><font style="display: inline;font-family:Calibri;">Vesting for your stock option </font><font style="display: inline;font-family:Calibri;">will </font><font style="display: inline;font-family:Calibri;">start on your first day of full-time employment</font><font style="display: inline;font-family:Calibri;"> with the Company</font><font style="display: inline;font-family:Calibri;">. &nbsp;</font><font style="display: inline;font-family:Calibri;">The strike price of your stock option will be priced on the closing price of </font><font style="display: inline;font-family:Calibri;">the</font><font style="display: inline;font-family:Calibri;"> first day of your full-time employment with the Company. </font><font style="display: inline;font-family:Calibri;">Your stock option will be issued pursuant to the &#x2018;2018 Omnibus Equity Incentive Plan&#x2019; and will be subject to all terms and conditions set forth in the agreement covering your stock option.</font><font style="display: inline;font-family:Calibri;"> From time</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">to</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">time </font><font style="display: inline;font-family:Calibri;">the Company may grant you, in its sole discretion, </font><font style="display: inline;font-family:Calibri;">additional stock options or other types of equity-based compensation.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">You will be eligible to receive welfare benefits </font><font style="display: inline;font-family:Calibri;font-size:12pt;">on the same terms and conditions as generally available to other o</font><font style="display: inline;font-family:Calibri;font-size:12pt;">fficers of </font><font style="display: inline;font-family:Calibri;font-size:12pt;">Cassava Sciences</font><font style="display: inline;font-family:Calibri;font-size:12pt;">, such as medical, life insurance, disability or other health benefits. </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">You agree to relocate to the Austin, Texas area as soon as practical but in any event no later than </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">December 1,</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;"> 202</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">2</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">. &nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">In the event you are unable or unwilling to relocate to Austin, your position may be eliminated, in which case you may no longer be constructively employed by Cassava Sciences and will not be provided a severance package.</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">You are also eligible to receive a one-time, </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">forty</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;"> thousand-dollar ($</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">4</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">0,000) relocation </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">package</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">. This relocation </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">package</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;"> constitutes the entire financial assistance Cassava Sciences will provide you regarding relocation. Such </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">amount</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;"> will be paid to you </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">approximately three months </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">after your </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">first date of full-time employment with the Company</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">, net of any withholdings required by law. Should you terminate employment with Cassava Sciences within one year of </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">your first date of full-time employment with the Company,</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;font-size:12pt;">you agree to reimburse the entire relocation bonus on your last day of full-time employment with Cassava Sciences.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">Other</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> key</font><font style="display: inline;font-family:Calibri;font-size:12pt;"> terms of this </font><font style="display: inline;font-family:Calibri;font-size:12pt;">o</font><font style="display: inline;font-family:Calibri;font-size:12pt;">ffer of </font><font style="display: inline;font-family:Calibri;font-size:12pt;">e</font><font style="display: inline;font-family:Calibri;font-size:12pt;">mployment are outlined below:</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">1.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">A proposed full-time start date is </font><font style="display: inline;font-family:Calibri;">no later than </font><font style="display: inline;font-family:Calibri;">Thursday</font><font style="display: inline;font-family:Calibri;">, &nbsp;</font><font style="display: inline;font-family:Calibri;">December 1,</font><font style="display: inline;font-family:Calibri;"> 2022.</font><font style="display: inline;font-family:Calibri;"> Of course, an earlier start date is acceptable and welcomed.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">2.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">An integral part of this position is the</font><font style="display: inline;font-family:Calibri;"> ability to </font><font style="display: inline;font-family:Calibri;">travel</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">as needed</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">without restrictions</font><font style="display: inline;font-family:Calibri;">.</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">Please inform </font><font style="display: inline;font-family:Calibri;">me immediately </font><font style="display: inline;font-family:Calibri;">in writing if you are aware of any </font><font style="display: inline;font-family:Calibri;">personal or other </font><font style="display: inline;font-family:Calibri;">restrictions that may impede your ability to engage in air </font><font style="display: inline;font-family:Calibri;">travel or other forms of </font><font style="display: inline;font-family:Calibri;">overnight </font><font style="display: inline;font-family:Calibri;">travel from time</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">to</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">time</font><font style="display: inline;font-family:Calibri;">, including overseas travel.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 10pt">

			<font style="display: inline;font-family:Calibri;font-size:10pt;">Page </font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;">2</font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;"> of </font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;">3</font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font>

		</p>

		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:center;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

			<font style="display: inline;font-family:Calibri;font-weight:bold;color:#C00000;">PERSONAL AND C</font><font style="display: inline;font-family:Calibri;font-weight:bold;color:#C00000;">ONFIDENTIAL</font>

		</p>

</div>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;;font-size: 12pt"><font style="display: inline;font-family:Calibri;">3.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">As an </font><font style="display: inline;font-family:Calibri;">O</font><font style="display: inline;font-family:Calibri;">fficer of Cassava Sciences, </font><font style="display: inline;font-family:Calibri;">you will not accrue, and the Company will not record, any specific amount of vacation time or time off. The ability to take paid time off is not intended to be a form of additional wages for services performed. Rather it is part of an effort to provide you with the benefits of a flexible work schedule. You are encouraged to rest </font><font style="display: inline;font-family:Calibri;">and</font><font style="display: inline;font-family:Calibri;"> rejuvenate as your work responsibilities allow. There are no consequences for taking time off, or for failing to take time off.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">4.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">Cassava Sciences</font><font style="display: inline;font-family:Calibri;"> will promptly reimburse your business and travel expenses</font><font style="display: inline;font-family:Calibri;"> in accordance with the Company&#x2019;s expense reimbursement policies.</font><font style="display: inline;font-family:Calibri;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;font-family:Calibri;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">5.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">In</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">the event your employment with Cassava Sciences is terminated without cause after your initial </font><font style="display: inline;font-family:Calibri;">six (</font><font style="display: inline;font-family:Calibri;">6</font><font style="display: inline;font-family:Calibri;">)</font><font style="display: inline;font-family:Calibri;"> months of employment, or in the event a &#x201C;constructive dismissal&#x201D; occurs at any time during your employment, you will be paid your regular base salary, and you will continue to receive employment benefits, for a period of </font><font style="display: inline;font-family:Calibri;">three (</font><font style="display: inline;font-family:Calibri;">3</font><font style="display: inline;font-family:Calibri;">)</font><font style="display: inline;font-family:Calibri;"> months following your last date of employment at the Company, or the date upon which you commence employment with another entity, </font><font style="display: inline;font-family:Calibri;font-style:italic;">provided, however</font><font style="display: inline;font-family:Calibri;">, you sign and do not revoke an employment separation and release agreement. </font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;font-family:Calibri;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">6.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">In the event your employment with Cassava Sciences is terminated without cause after a &#x201C;Change in Control&#x201D; (as defined herein) you will be paid your regular base salary, and you will continue to receive employment benefits, for a period of </font><font style="display: inline;font-family:Calibri;">twelve (</font><font style="display: inline;font-family:Calibri;">12</font><font style="display: inline;font-family:Calibri;">)</font><font style="display: inline;font-family:Calibri;"> months following your last date of employment with the Company. A &#x2018;Change-in-Control&#x2019; means the acquisition of </font><font style="display: inline;font-family:Calibri;">fifty-one percent (</font><font style="display: inline;font-family:Calibri;">51%</font><font style="display: inline;font-family:Calibri;">)</font><font style="display: inline;font-family:Calibri;"> or more of Cassava Sciences&#x2019; then outstanding shares at the time of a Change-in-Control transaction, </font><font style="display: inline;font-family:Calibri;font-style:italic;">provided, however</font><font style="display: inline;font-family:Calibri;">, &nbsp;</font><font style="display: inline;font-family:Calibri;">that </font><font style="display: inline;font-family:Calibri;">you sign and do not revoke an employment separation and release agreement, and </font><font style="display: inline;font-family:Calibri;font-style:italic;">further</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-style:italic;">provided, however</font><font style="display: inline;font-family:Calibri;">, that for purposes of this Paragraph 6, raising capital through the issuance of equity by the Company shall not constitute a Change-in-Control</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;font-family:Calibri;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">7.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;font-weight:bold;">Y</font><font style="display: inline;font-family:Calibri;font-weight:bold;">ou</font><font style="display: inline;font-family:Calibri;font-weight:bold;"> acknowledge and agree that your</font><font style="display: inline;font-family:Calibri;font-weight:bold;"> employment with </font><font style="display: inline;font-family:Calibri;font-weight:bold;">Cassava Sciences</font><font style="display: inline;font-family:Calibri;font-weight:bold;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-weight:bold;">is for no specified time and constitutes</font><font style="display: inline;font-family:Calibri;font-weight:bold;"> &#x201C;at-will&#x201D;</font><font style="display: inline;font-family:Calibri;font-weight:bold;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-weight:bold;">employment</font><font style="display: inline;font-family:Calibri;font-weight:bold;">.</font><font style="display: inline;font-family:Calibri;"> &nbsp;As a result, you are free to resign at any time</font><font style="display: inline;font-family:Calibri;">,</font><font style="display: inline;font-family:Calibri;"> for any reason</font><font style="display: inline;font-family:Calibri;">. In</font><font style="display: inline;font-family:Calibri;"> the event of resignation, </font><font style="display: inline;font-family:Calibri;">please</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">provide </font><font style="display: inline;font-family:Calibri;">at least </font><font style="display: inline;font-family:Calibri;">three</font><font style="display: inline;font-family:Calibri;"> weeks</font><font style="display: inline;font-family:Calibri;">&#x2019;</font><font style="display: inline;font-family:Calibri;"> notice in order to effect a smooth transition of the Company&#x2019;s affairs.</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">Similarly, </font><font style="display: inline;font-family:Calibri;">the Company</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">is free to conclude its employment relationship with you at any </font><font style="display: inline;font-family:Calibri;">time and</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">reserves the right to make personnel decisions regarding your employment, including but not limited to, promotions, salary adjustment, scope of responsibilities, transfer </font><font style="display: inline;font-family:Calibri;">or</font><font style="display: inline;font-family:Calibri;"> termination</font><font style="display: inline;font-family:Calibri;">, &nbsp;</font><font style="display: inline;font-family:Calibri;">consistent with </font><font style="display: inline;font-family:Calibri;">the Company&#x2019;s</font><font style="display: inline;font-family:Calibri;"> needs.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">8.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">You and </font><font style="display: inline;font-family:Calibri;">Cassava Sciences </font><font style="display: inline;font-family:Calibri;">shall attempt in good faith to resolve any dispute or claim</font><font style="display: inline;font-family:Calibri;"> arising out of your employment</font><font style="display: inline;font-family:Calibri;">,</font><font style="display: inline;font-family:Calibri;"> or its termination</font><font style="display: inline;font-family:Calibri;">,</font><font style="display: inline;font-family:Calibri;"> through discussion, evaluation, negotiation</font><font style="display: inline;font-family:Calibri;"> and</font><font style="display: inline;font-family:Calibri;"> conciliation</font><font style="display: inline;font-family:Calibri;">.</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;"> If a dispute cannot be amicably settled </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 10pt">

			<font style="display: inline;font-family:Calibri;font-size:10pt;">Page </font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;">3</font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;"> of </font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;">3</font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font>

		</p>

		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:center;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

			<font style="display: inline;font-family:Calibri;font-weight:bold;color:#C00000;">PERSONAL AND C</font><font style="display: inline;font-family:Calibri;font-weight:bold;color:#C00000;">ONFIDENTIAL</font>

		</p>

</div>
		<p style="margin:0pt 0pt 0pt 36pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt"><font style="display: inline;font-family:Calibri;">within six-weeks from the date on which a party has served written notice to the other party of a dispute, then the matter </font><font style="display: inline;font-family:Calibri;">shall be submitted to binding arbitration before a neutral arbitrator in Texas, except where Texas law specifically forbids the use of arbitration as a final and binding remedy.&nbsp;&nbsp;In the event of arbitration or other legal action, each party shall bear its own </font><font style="display: inline;font-family:Calibri;">fees and </font><font style="display: inline;font-family:Calibri;">expenses.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">9.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 10.8pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">You understand and agree this is an offer of full-time and exclusive </font><font style="display: inline;font-family:Calibri;">employment </font><font style="display: inline;font-family:Calibri;">for </font><font style="display: inline;font-family:Calibri;">Cassava Sciences </font><font style="display: inline;font-family:Calibri;">and is office-</font><font style="display: inline;font-family:Calibri;">based</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">in Austin, TX</font><font style="display: inline;font-family:Calibri;">.</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">You</font><font style="display: inline;font-family:Calibri;"> may not consult or provide professional </font><font style="display: inline;font-family:Calibri;">services, with or without compensation,</font><font style="display: inline;font-family:Calibri;"> to </font><font style="display: inline;font-family:Calibri;">any </font><font style="display: inline;font-family:Calibri;">third </font><font style="display: inline;font-family:Calibri;">party</font><font style="display: inline;font-family:Calibri;"> at any time during your employment with </font><font style="display: inline;font-family:Calibri;">the Company</font><font style="display: inline;font-family:Calibri;">.</font><font style="display: inline;font-family:Calibri;"> If you wish to request consent to provide services (for any or no form of compensation) to any other person or business entity while employed by </font><font style="display: inline;font-family:Calibri;">the Company</font><font style="display: inline;font-family:Calibri;">, you must first receive </font><font style="display: inline;font-family:Calibri;">express </font><font style="display: inline;font-family:Calibri;">written permission from the </font><font style="display: inline;font-family:Calibri;">CEO</font><font style="display: inline;font-family:Calibri;">, which may be withheld</font><font style="display: inline;font-family:Calibri;">.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">10.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 7.2pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">You represent to </font><font style="display: inline;font-family:Calibri;">Cassava Sciences</font><font style="display: inline;font-family:Calibri;"> that you are not subject to any commitment</font><font style="display: inline;font-family:Calibri;"> or</font><font style="display: inline;font-family:Calibri;"> obligation that would </font><font style="display: inline;font-family:Calibri;">legally or ethically </font><font style="display: inline;font-family:Calibri;">prevent you </font><font style="display: inline;font-family:Calibri;">from </font><font style="display: inline;font-family:Calibri;">accepting </font><font style="display: inline;font-family:Calibri;">this offer of </font><font style="display: inline;font-family:Calibri;">employment</font><font style="display: inline;font-family:Calibri;">, or that may in any way interfere or restrict you from </font><font style="display: inline;font-family:Calibri;">performing the duties and responsibilities contemplated in this </font><font style="display: inline;font-family:Calibri;">Letter </font><font style="display: inline;font-family:Calibri;">Agreement. You further acknowledge that the Company has directed you to not misappropriate any confidential information or trade secrets from any prior employer or third party for use in the performance of your duties and responsibilities with </font><font style="display: inline;font-family:Calibri;">the Company.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">11.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 7.2pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">You agree to </font><font style="display: inline;font-family:Calibri;">review and </font><font style="display: inline;font-family:Calibri;">sign a &#x201C;CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT&#x201D;</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">(attached).</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;font-family:Calibri;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">12.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 7.2pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">You agree to acknowledge in writing that you have read and understand the Company&#x2019;s &#x201C;INSIDER TRADING COMPLIANCE PROGRAM&#x201D; (attached).</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">13.</font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 7.2pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;">This offer expires</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">on </font><font style="display: inline;font-family:Calibri;">Thursday, October 27, 2022</font><font style="display: inline;font-family:Calibri;">,</font><font style="display: inline;font-family:Calibri;"> unless signed by you and received by </font><font style="display: inline;font-family:Calibri;">Cassava Sciences </font><font style="display: inline;font-family:Calibri;">before then.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Finally, please note that all e</font><font style="display: inline;font-family:Calibri;">mployees of Cassava Sciences are fully vaccinated against Covid-19. Prior to your start date you may be required to show evidence that you have received a Covid-19 vaccine or have a valid religious or medical reason not to be vaccinated in accordance with EEOC issued guidelines.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">If</font><font style="display: inline;font-family:Calibri;"> the conditions of this offer and your acceptance are satisfied, this </font><font style="display: inline;font-family:Calibri;">L</font><font style="display: inline;font-family:Calibri;">etter </font><font style="display: inline;font-family:Calibri;">Agreement </font><font style="display: inline;font-family:Calibri;">shall constitute the full and complete agreement between you and </font><font style="display: inline;font-family:Calibri;">Cassava Sciences </font><font style="display: inline;font-family:Calibri;">regarding the terms and conditions of your employment.</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">This </font><font style="display: inline;font-family:Calibri;">L</font><font style="display: inline;font-family:Calibri;">etter </font><font style="display: inline;font-family:Calibri;">Agreement </font><font style="display: inline;font-family:Calibri;">specifically </font><font style="display: inline;font-family:Calibri;">cancel</font><font style="display: inline;font-family:Calibri;">s</font><font style="display: inline;font-family:Calibri;">, supersede</font><font style="display: inline;font-family:Calibri;">s</font><font style="display: inline;font-family:Calibri;"> and replace</font><font style="display: inline;font-family:Calibri;">s</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">all</font><font style="display: inline;font-family:Calibri;"> prior negotiations, representations or agreements, written and oral, between you and </font><font style="display: inline;font-family:Calibri;">anyone at </font><font style="display: inline;font-family:Calibri;">Cassava Sciences</font><font style="display: inline;font-family:Calibri;"> or </font><font style="display: inline;font-family:Calibri;">its </font><font style="display: inline;font-family:Calibri;">recruiting agents,</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">regarding any aspect of your employment. Any change to the terms of your employment with </font><font style="display: inline;font-family:Calibri;">Cassava Sciences</font><font style="display: inline;font-family:Calibri;">, as set forth in this letter, must be </font><font style="display: inline;font-family:Calibri;">made </font><font style="display: inline;font-family:Calibri;">in writing to you, signed by </font><font style="display: inline;font-family:Calibri;">the CEO of </font><font style="display: inline;font-family:Calibri;">Cassava Sciences</font><font style="display: inline;font-family:Calibri;">,</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">to be effective.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 10pt">

			<font style="display: inline;font-family:Calibri;font-size:10pt;">Page </font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;">4</font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;"> of </font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;">3</font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font>

		</p>

		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:center;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

			<font style="display: inline;font-family:Calibri;font-weight:bold;color:#C00000;">PERSONAL AND C</font><font style="display: inline;font-family:Calibri;font-weight:bold;color:#C00000;">ONFIDENTIAL</font>

		</p>

</div>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;punctuation-wrap:hanging;line-height:100%;;font-size: 12pt"><font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">If </font><font style="display: inline;font-family:Calibri;">these terms and condition of e</font><font style="display: inline;font-family:Calibri;">mployment</font><font style="display: inline;font-family:Calibri;"> and the attached Invention Agreement </font><font style="display: inline;font-family:Calibri;">are</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">acceptable to you, please sign, date and </font><font style="display: inline;font-family:Calibri;">return </font><font style="display: inline;font-family:Calibri;">to the Company </font><font style="display: inline;font-family:Calibri;">one original copy.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Chris,</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">we all</font><font style="display: inline;font-family:Calibri;"> very much l</font><font style="display: inline;font-family:Calibri;">ook forward to working</font><font style="display: inline;font-family:Calibri;"> with you</font><font style="display: inline;font-family:Calibri;">!</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;font-family:Times;font-size: 12pt">
			<br /><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">/s/ REMI BARBIER</font><font style="display: inline;font-family:Calibri;text-decoration:underline;"></font>
		</p>
		<p style="margin:3pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;">Remi Barbier</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;">Chairman of the Board</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;">President &amp; CEO</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">I &nbsp;</font><font style="display: inline;font-family:Calibri;">have read</font><font style="display: inline;font-family:Calibri;"> and </font><font style="display: inline;font-family:Calibri;">understood </font><font style="display: inline;font-family:Calibri;">this Letter Agreement </font><font style="display: inline;font-family:Calibri;">and </font><font style="display: inline;font-family:Calibri;">accept and </font><font style="display: inline;font-family:Calibri;">agree to all </font><font style="display: inline;font-family:Calibri;">of its</font><font style="display: inline;font-family:Calibri;"> terms and condition</font><font style="display: inline;font-family:Calibri;">s</font><font style="display: inline;font-family:Calibri;">. I further acknowledge that no other commitments or enticements were made to me as part of this offer of employment, except as specified herein.</font>
		</p>
		<p style="margin:0pt 36pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;punctuation-wrap:hanging;font-family:Times;font-size: 12pt">
			<br /><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">/s/ R</font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">. CHRISTOPHER COOK</font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;text-decoration:underline;"></font><font style="display: inline;font-family:Calibri;text-decoration:underline;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;text-decoration:underline;"></font><font style="display: inline;font-family:Calibri;text-decoration:underline;">10/13/2022</font><font style="display: inline;font-family:Calibri;text-decoration:underline;"></font>
		</p>
		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;">R. Christopher Cook</font><font style="display: inline;font-family:Calibri;font-weight:bold;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;font-weight:bold;"></font><font style="display: inline;font-family:Calibri;font-weight:bold;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;;font-size: 12pt;font-family:Times;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Calibri;"></font><font style="display: inline;font-family:Calibri;font-weight:bold;">Date</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;color:#000000;punctuation-wrap:hanging;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-style:italic;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;color:#000000;punctuation-wrap:hanging;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-style:italic;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;color:#000000;punctuation-wrap:hanging;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-style:italic;">Attachments</font><font style="display: inline;font-family:Calibri;font-style:italic;">: &nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;color:#000000;punctuation-wrap:hanging;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Confidential Information and Invention Assignment Agreement</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;color:#000000;punctuation-wrap:hanging;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Insider Trading Compliance Program</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;color:#000000;punctuation-wrap:hanging;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Benefits Summary</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;color:#000000;punctuation-wrap:hanging;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Employee Handbook</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;color:#000000;punctuation-wrap:hanging;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">XXXXXXXXX</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;color:#000000;punctuation-wrap:hanging;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Form of Stock Option Agreement</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;color:#000000;punctuation-wrap:hanging;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 10pt">

			<font style="display: inline;font-family:Calibri;font-size:10pt;">Page </font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;">5</font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;"> of </font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font><font style="display: inline;font-family:Calibri;font-size:10pt;">3</font><font style="display: inline;font-family:Calibri;font-size:10pt;"></font>

		</p>

		<p style="margin:0pt;punctuation-wrap:hanging;line-height:100%;font-family:Times;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>sava-20221013xex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 22.2.0.1-->
<!--Created on: 10/27/2022 3:00:03 PM-->
<html>
	<head>
		<title>
			Exhibit 991 - 2022 General Counsel
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<a name="_Hlk6492065"></a><font style="display: inline;"><img src="sava-20221013xex99_1g001.jpg" style="width: 5.409161in; height: 1.770691in" alt="Picture 1"></font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Sansation;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Sansation;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Sansation;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Sansation;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Sansation;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 3pt;text-align:right;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 24pt">
			<font style="display: inline;font-family:Sansation;font-weight:bold;;font-size: 24pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:24pt;"></font><font style="display: inline;font-family:Calibri;font-weight:bold;">Exhibit 99.1</font>
		</p>
		<p style="margin:0pt 0pt 3pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 24pt">
			<font style="display: inline;font-family:Sansation;font-weight:bold;font-size:24pt;">Cassava Sciences Announces Expansion of</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:24pt;">&nbsp;</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:24pt;">Leadership Team</font>
		</p>
		<p style="margin:0pt 0pt 6pt 36pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;font-size:14pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:0pt;"><p style="width:0pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 13.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 14pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:14pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 14pt;margin:0pt 0pt 12pt;">
			<font style="display: inline;font-family:Calibri;font-weight:bold;font-size:14pt;color:#000000;">Chris Cook</font><font style="display: inline;font-family:Calibri;font-weight:bold;font-size:14pt;color:#000000;">, A Skilled Litigator, To Join Management Team as </font><font style="display: inline;font-family:Calibri;font-weight:bold;font-size:14pt;color:#000000;">General Counsel</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:0pt;"><p style="width:0pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 13.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 14pt;margin:0pt 0pt 24pt;">
				<font style="margin:0pt 0pt 24pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:14pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 14pt;margin:0pt 0pt 24pt;">
			<font style="display: inline;font-family:Calibri;font-weight:bold;font-size:14pt;color:#000000;">New Position Is Expected to Be Critical to Operations and Strategic Initiatives</font></p></td></tr></table></div>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;color:#000000;">AUSTIN, Texas &#x2013; </font><font style="display: inline;font-family:Calibri;font-weight:bold;color:#000000;">October </font><font style="display: inline;font-family:Calibri;font-weight:bold;color:#000000;">27</font><font style="display: inline;font-family:Calibri;font-weight:bold;color:#000000;">, 2022</font><font style="display: inline;font-family:Calibri;color:#000000;"> &#x2013; Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">biotechnology company focused on Alzheimer&#x2019;s disease, </font><font style="display: inline;font-family:Calibri;color:#000000;">announced</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">the</font><font style="display: inline;font-family:Calibri;color:#000000;"> expansion of its leadership team with the appointment of Christopher Cook as Senior Vice President and General Counsel</font><font style="display: inline;font-family:Calibri;color:#000000;">. This is</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">a newly created position</font><font style="display: inline;font-family:Calibri;color:#000000;">,</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">reporting</font><font style="display: inline;font-family:Calibri;color:#000000;"> to Remi Barbier, President &amp; CEO.</font><font style="display: inline;font-family:Calibri;color:#000000;"> &nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;color:#000000;">&#x201C;Chris is an accomplished legal advisor, a skilled litigator and a proven leader in legal matters,&#x201D; </font><font style="display: inline;font-family:Calibri;color:#000000;">said Remi Barbier.</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">"</font><font style="display: inline;font-family:Calibri;color:#000000;">We&#x2019;re very excited </font><font style="display: inline;font-family:Calibri;color:#000000;">that </font><font style="display: inline;font-family:Calibri;color:#000000;">Chris</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">will shortly join</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">us </font><font style="display: inline;font-family:Calibri;color:#000000;">as </font><font style="display: inline;font-family:Calibri;color:#000000;">Cassava Sciences&#x2019; </font><font style="display: inline;font-family:Calibri;color:#000000;">in-house General Counsel</font><font style="display: inline;font-family:Calibri;color:#000000;">.</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">I&#x2019;m confident h</font><font style="display: inline;font-family:Calibri;color:#000000;">is </font><font style="display: inline;font-family:Calibri;color:#000000;">experience and </font><font style="display: inline;font-family:Calibri;color:#000000;">deep expertise will be a critical addition to </font><font style="display: inline;font-family:Calibri;color:#000000;">the Company&#x2019;s </font><font style="display: inline;font-family:Calibri;color:#000000;">business </font><font style="display: inline;font-family:Calibri;color:#000000;">operations and </font><font style="display: inline;font-family:Calibri;color:#000000;">strategic initiatives</font><font style="display: inline;font-family:Calibri;color:#000000;">.</font><font style="display: inline;font-family:Calibri;color:#000000;">&#x201D;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-family:Calibri;font-size:11pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;color:#000000;">Chris has over 25 years of experience working in health care, private practice and government. He </font><font style="display: inline;font-family:Calibri;color:#000000;">joins Cassava Sciences from Alcon, </font><font style="display: inline;font-family:Calibri;color:#000000;">a publicly traded medical company, </font><font style="display: inline;font-family:Calibri;color:#000000;">where he served as the Global Head of Litigation and Government Investigations since 2017.</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">Prior to Alcon, he was the Vice President and division General Counsel for Walmart Central America in San Jose, Costa Rica.</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">Chris</font><font style="display: inline;font-family:Calibri;color:#000000;"> practiced law at Jones Day</font><font style="display: inline;font-family:Calibri;color:#000000;">, a multinational law firm, </font><font style="display: inline;font-family:Calibri;color:#000000;">for seventeen years, where he was a litigation partner in the firm's Washington, DC and Chicago offices.</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">Before Jones Day, </font><font style="display: inline;font-family:Calibri;color:#000000;">Chris</font><font style="display: inline;font-family:Calibri;color:#000000;"> served as an Assistant United States Attorney in Chicago.</font><font style="display: inline;font-family:Calibri;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Calibri;color:#000000;">He holds a B.A. in English from Emory University and a Juris Doctor from Harvard Law School.</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;;font-size: 12pt"><font style="font-weight:bold;display: inline;font-family:Calibri;">Phase 3 Clinical Program </font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Cassava Sciences&#x2019; on-going Phase 3 program consists of two double-blind, randomized, placebo-controlled studies of simufilam, an investigational oral drug, in approximately 1,</font><font style="display: inline;font-family:Calibri;">750</font><font style="display: inline;font-family:Calibri;"> patients with mild-to-moderate Alzheimer&#x2019;s disease. Both Phase 3 studies have Special Protocol Assessments (SPA) from the U.S. Food and Drug Administration. </font><font style="display: inline;font-family:Calibri;">For more information about </font><font style="display: inline;font-family:Calibri;">Cassava Sciences&#x2019;</font><font style="display: inline;font-family:Calibri;"> Phase 3 studies, please visit ClinicalTrials.gov: </font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font><font style="display: inline;font-family:Calibri;">https://www.clinicaltrials.gov/ct2/show/NCT04994483?term=simufilam&amp;draw=2&amp;rank=3</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="font-weight:bold;display: inline;font-family:Calibri;">&#xFEFF;</font><font style="display: inline;font-family:Calibri;">https://www.clinicaltrials.gov/ct2/show/NCT05026177?term=simufilam&amp;draw=2&amp;rank=4</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="font-weight:bold;display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="font-weight:bold;display: inline;font-family:Calibri;">About Simufilam</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Simufilam is Cassava Sciences&#x2019; proprietary, small molecule (oral) drug </font><font style="display: inline;font-family:Calibri;">candidate </font><font style="display: inline;font-family:Calibri;">that restores the normal shape and function of altered filamin A (FLNA) protein in the brain. Cassava Sciences owns worldwide development and commercial rights to its research programs in Alzheimer&#x2019;s disease, and related technologies, without royalty obligations to any third party.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="font-weight:bold;display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="font-weight:bold;display: inline;font-family:Calibri;">About Cassava Sciences, Inc.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Cassava Sciences, Inc. is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer&#x2019;s disease. Our novel science is based on stabilizing &#x2013; but not removing &#x2013; a critical protein in the brain. For more information, please visit: </font><font style="display: inline;font-family:Calibri;">https://www.CassavaSciences.com</font><font style="display: inline;font-family:Calibri;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="font-weight:bold;display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="font-weight:bold;display: inline;font-family:Calibri;">For More Information Contact: </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Eric Schoen, Chief Financial Officer</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">(512) 501-2450</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font><font style="display: inline;font-family:Calibri;">eschoen@CassavaSciences.com</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 9pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;font-style:italic;font-size:9pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">###</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>sava-20221013xex10_1g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sava-20221013xex10_1g001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /?Z***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"[F
M\J+ ^\W J<D 9/ %9$\IFE+=N@^E<>-K^RIV6[-*4.9D5%%%?/G8%%%% "$
M@@C(/4&N>O+<VUPR?PGE3[5T55;^V^T6YVCYTY7_  K.I'F1O0J<DM=F8%%%
M%<IZ04444 %:^G6_E1>8P^9^GL*H6=O]HG (^1>6_P *W*:.'%U=.1!1115'
M %%%% $]I/Y$P)/RGAJVJYZM6PG\R+RV/S)T]Q7M95B;/V,OD8U(]2Y1117N
MF(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-D
M<1H7;H!2;25V!5OIMJ^4O5NOTK/ISN9'9VZDTVOF\36=:HY=.AVPCRJP4445
M@6%%%% !1110!AZE;>3/YBCY'Y^A[U2KI+F!;B!HSWZ'T-<XRE'*L,,#@BN6
MI&SN>CAZG-&SW0E'4X%%7M.M_,E\UA\J=/<U!K4FH1<F7[2#[/ %/WCRWUJ>
MBBJ/&E)R=V%%%% @HHHH *DAE,,JN.QY'K4=%.,G%J2W0CH$8.@93D$9%+6=
MIT_)A8^ZUHU]=A:ZKTE-?TSFDK.P4445T$A1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !6??3;G\I3PO7ZU9N[J.T@,DDBIG@%C@9K#-]:
MDY-U"2?^F@KS<PK-1]G'KN=%"DW[UB>BH/MUI_S]0?\ ?P4?;K3_ )^H/^_@
MKQN678ZN278GHJ#[=:?\_4'_ '\%'VZT_P"?J#_OX*.678.278GHJ#[=:?\
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M?UK%F\?^+9W+/X@OP3_SSE*#\EQ7.45LH16R(YGW-X>-_%0.?^$BU3_P*?\
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M]PU[>ID&WM<-M89X9NB\C!')'I7$?%;XDW"74WAS1)S$(_EO+F-OF+=XU(Z
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M'VBW!_YZ*/F ]RH!_P" 5G7I+EO%;#IS=[,]THHHKB.@**** "BBB@ HHHH
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MSRO5HU.>%SFG&S'1R/#*DL;%71@RL.H(Z&O6-)U%-4TV&Z7 9AAU'\+#J/\
M/;%>2UTW@W5?LFHFRD8"&Y.%SV?M^?3\JC$T^:-UNATY6=CT&BBBO-.@****
M ,[7-372=+DN.#(?DB![L>G^/X5Y4S,[L[L69CDDGDFMWQ7JO]I:H8XVS!;Y
M1?0GN?Z?A6#7IX>GR1N]V<]25V%=!X1TO[?JHGD7,%MASGNW\(_K^'O6 JEV
M"J"6)P .]>JZ'I@TK2HK?CS#\\I'=CU_+I^%&(J<D++=A3C=FC1117F'0%>>
M?&+Q%_8W@YK&*3;=:FQA4 D$1CF0_D0O_ Z]#KYB^*?B+_A(/&UT(VS:V/\
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M2ET.]HHHKC-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M? ?5$DT;5-*)'F0W N%R>2KJ%.![%/\ QZO7:\VJK39U0=XH****S*"BBB@
MHHHH **** &331V\$DTSJD4:EW=C@* ,DFOD?Q1KDGB3Q-?ZLX(%Q*3&IZJ@
MX4?4*!7NWQD\1'1_!_V"%]MSJ;&$8ZB,8+G]0OT:OG*NS#0LN8PJRUL%?3OP
MK\/_ -@^![0R+BYOO]*ESVW ;1T[*%X]2:\#\#^'SXF\7V&G,A:W+^9<<' B
M7ELD=,_=SZL*^KW=(HV=V5$0$LS'  '>C$SVB%)=3/OO$&BZ7<?9]0U>PM)B
MNX1SW*(V/7!/3BJW_"8^%_\ H8](_P# V/\ QKYA\5ZV_B/Q1J&JMG;/*?+!
M&"(QP@^NT"L:A896U8W5/9/C-)H.LV-CJNF:OIUS>V[>3)'!<H[M&>0< Y.U
ML_\ ?9KQNBBNB$>2-C*3N[G1>!_$3>%_%UCJ+.RVX?R[D#/,3<-D#KC[P'JH
MKZO!! (.0>A%?%U?2_PF\1C7?!4$$C9NM.Q;2#N5 ^1O^^>/JIKGQ,-.8TI2
MZ'=T445QFY4U/3++6-.FL-0MTGM9EVO&XZ^X]".H(Y!KPKQ/\%=7T^9YM!<:
MC:'D1.P29!^. WU&"?2OH"BM(5)0V)E%2W/CF^TC4M,;;?Z?=VA/:>%D_F*I
MU]I4SRHS_P LU_*M_K7D9^Q\SXPHK[/\J/\ YYI_WR*9):V\T;1RV\3HPP59
M 0?PH^M>0>Q\SXSHKZ1\9?"K1-;TR:72K*'3]3C3,)MU"1R$?PLHXYZ9'(X/
M.,'YN((.#6].HIK0SE%QW.I\!>+I_"/B2&Y\QOL$S".\CZADS]['JO4=^H[F
MOJ@$, 0001D$=Z^+J^J_AU?G4OA]HMPW5;?R3_VS)3_V6L,3%:2-*3Z"^,?!
M&F>,[ 178,-U&#Y%T@^:,^A'\2^WY$=:\)U[X5>*M$D9H[%M0M\X66R!D)SZ
MI]X>_&/>OIRBL:=:4-$7*"D?&4]M/:R&.X@DAD'59$*D?@:BK[1(!&" 1[TW
MRH_^>:?]\BMOK7D1['S/C"BOL_RH_P#GFG_?(JM>:3INHQ"*^T^UNHP<A)X5
M<9^A%/ZUY!['S/CFBO6_BK\-['0[ :[HD1AM@X2YM]Q*INX#KGD#/!'N,5Y)
M71":FKHRE%Q=F>S?!3QA+]H?PO>2;HV5I;)F/*D<L@]L98>F&]>/;*^1/"M^
MVF>+-)O5=D$5W&6*G!*[@&'XC(_&OKNN/$12E==3>D[JP5'<7$5I;2W-Q(L<
M,2&21V/"J!DD_A4E>;?&?Q%_97A-=,A;%QJ;[#@\B)<%_P _E7Z$UC"/-)(N
M3LKGA7B36I?$/B._U:4$&YE+*IZJ@X5?P4 ?A67172^ O#W_  DWC&PL'3=;
M*_G7/&1Y:\D'TSPN?]JO3=HKT.35L]\^&/A\^'O ]G'*NVYN_P#2IASP7 P.
M>A"A01ZYK>O?$6B:;<&WO]8T^UG !,<]RB-@]#@G-:$LL=O!)-*X2*-2SLQP
M% &2:^1O$VM2>(O$NH:M)D?:)2R*>JH.$7\% 'X5PTX>UDVSHE+D22/J'_A,
M?"__ $,>D?\ @;'_ (UY1\9WT+6+>PU;3-7TZZNX2;>6."Y1W:,Y*G /0'/_
M 'U7C]%=$*"A*Z9G*I=6"NE\!>(SX7\865^[E;9F\FYYX\IN"3ZXX;'^S7-4
M5LTFK,S3L[GVEU&117$?"OQ'_P )!X*MEE<-=V/^BS>I"CY&_%<<]R#7;UY<
MHN+LSK3NKA1112&>7^)-+_LO5G1%Q!+^\BP. #U'X'],5D5Z;XGTK^T])?8N
M;B']Y'@<GU7\1^H%>95ZE"ISPUW1S3C9A7J'AS5/[5TE'=LSQ_)+]1W_ !']
M:\OK0TK6+K1YWEMBAWC#(X)4^E%>E[2.FX0ERL[#QEJWV2P%C$V)K@?-CJ$[
M_GT_.O/ZLW]]/J-Y)=7# R.>@& !V ]JK55&G[.-@E+F=PKJ_!6E^?=OJ$@^
M2'Y8_=R.3^ _G[5S$$$ES<1P0KNDD8*H]2:]9TZRCT[3X;2/E8UP3ZGN?Q-9
MXFIRQY5U'3C=W+5%%%>:= 52UC5(-%T:\U.Y_P!3:Q-(PS@M@< >Y/ ^M7:\
MA^.?B(V^FV?A^%\/='[1< '_ )9J<*#[%@3_ , JZ<>:21,G97/%-0OI]3U&
MYO[EMT]S*TLA'3<QR?PJN 68  DDX '>DKNOA+X?.M^.+::1";;3_P#2I#@X
MW _(,^N[!QW"FO1DU&-SF2N['O?@W05\->$]/TO $L<>Z<\',C<MR.HR<#V
MJQ=^)M!L+I[:\UO3K>XCQOBFND1ER,C()R.#5K5-1@TG2KO4;DXAMHFE?U(
MS@>YZ5\@ZA?3:GJ5U?W)!GN96ED('&YCD_SKBIT_:MMF\I<FB/J[_A,?"_\
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M?#_SU3_OH46869)14?GP_P#/5/\ OH4>?#_SU3_OH46869)14?GP_P#/5/\
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MC\4OZ9>B;(P>U256!P0?2K .1D5]'%GP=:%G="T4451@%%%% !1110 4444
M%>A^#](^Q:?]LE7$]P,C/\*=OSZ_E7*>&])_M75%5U)MXOGE/8CLOX_RS7I_
M2N+%5/L(VIQZA1117";!1110 48!ZBBB@!-J^@_*EHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *3 /44M% ";5_NC\J6BB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %<;XSTK#+J<2\'"3 ?H?Z?E795'/!'<V\D$R[HY%*L/:FG8
MWPU=T*BFCR&BK>I6,FFW\MK)G*'Y6Q]Y>QJI6A]9&2DE);,****!A4%W.+>
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MT+9][^T+?'U\Q:T]VK"[1.L)6/4/C_\ \R]_V\_^TJXKX38_X6;H^<=9NO\
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M=BS6EP23DGRC_A6T==3['!U858JI<JT59_LZ]_Y\[C_OTW^%']G7O_/G<?\
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M=&M-+LP1;VT812W5O4GW)R3]:OT45RMW-@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>sava-20221013xex99_1g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sava-20221013xex99_1g001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /?Z***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"[F
M\J+ ^\W J<D 9/ %9$\IFE+=N@^E<>-K^RIV6[-*4.9D5%%%?/G8%%%% "$
M@@C(/4&N>O+<VUPR?PGE3[5T55;^V^T6YVCYTY7_  K.I'F1O0J<DM=F8%%%
M%<IZ04444 %:^G6_E1>8P^9^GL*H6=O]HG (^1>6_P *W*:.'%U=.1!1115'
M %%%% $]I/Y$P)/RGAJVJYZM6PG\R+RV/S)T]Q7M95B;/V,OD8U(]2Y1117N
MF(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-D
M<1H7;H!2;25V!5OIMJ^4O5NOTK/ISN9'9VZDTVOF\36=:HY=.AVPCRJP4445
M@6%%%% !1110!AZE;>3/YBCY'Y^A[U2KI+F!;B!HSWZ'T-<XRE'*L,,#@BN6
MI&SN>CAZG-&SW0E'4X%%7M.M_,E\UA\J=/<U!K4FH1<F7[2#[/ %/WCRWUJ>
MBBJ/&E)R=V%%%% @HHHH *DAE,,JN.QY'K4=%.,G%J2W0CH$8.@93D$9%+6=
MIT_)A8^ZUHU]=A:ZKTE-?TSFDK.P4445T$A1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !6??3;G\I3PO7ZU9N[J.T@,DDBIG@%C@9K#-]:
MDY-U"2?^F@KS<PK-1]G'KN=%"DW[UB>BH/MUI_S]0?\ ?P4?;K3_ )^H/^_@
MKQN678ZN278GHJ#[=:?\_4'_ '\%'VZT_P"?J#_OX*.678.278GHJ#[=:?\
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M?UK%F\?^+9W+/X@OP3_SSE*#\EQ7.45LH16R(YGW-X>-_%0.?^$BU3_P*?\
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M]PU[>ID&WM<-M89X9NB\C!')'I7$?%;XDW"74WAS1)S$(_EO+F-OF+=XU(Z
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M'VBW!_YZ*/F ]RH!_P" 5G7I+EO%;#IS=[,]THHHKB.@**** "BBB@ HHHH
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MSRO5HU.>%SFG&S'1R/#*DL;%71@RL.H(Z&O6-)U%-4TV&Z7 9AAU'\+#J/\
M/;%>2UTW@W5?LFHFRD8"&Y.%SV?M^?3\JC$T^:-UNATY6=CT&BBBO-.@****
M ,[7-372=+DN.#(?DB![L>G^/X5Y4S,[L[L69CDDGDFMWQ7JO]I:H8XVS!;Y
M1?0GN?Z?A6#7IX>GR1N]V<]25V%=!X1TO[?JHGD7,%MASGNW\(_K^'O6 JEV
M"J"6)P .]>JZ'I@TK2HK?CS#\\I'=CU_+I^%&(J<D++=A3C=FC1117F'0%>>
M?&+Q%_8W@YK&*3;=:FQA4 D$1CF0_D0O_ Z]#KYB^*?B+_A(/&UT(VS:V/\
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M2ET.]HHHKC-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M? ?5$DT;5-*)'F0W N%R>2KJ%.![%/\ QZO7:\VJK39U0=XH****S*"BBB@
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MW _(,^N[!QW"FO1DU&-SF2N['O?@W05\->$]/TO $L<>Z<\',C<MR.HR<#V
MJQ=^)M!L+I[:\UO3K>XCQOBFND1ER,C()R.#5K5-1@TG2KO4;DXAMHFE?U(
MS@>YZ5\@ZA?3:GJ5U?W)!GN96ED('&YCD_SKBIT_:MMF\I<FB/J[_A,?"_\
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M?#_SU3_OH46869)14?GP_P#/5/\ OH4>?#_SU3_OH46869)14?GP_P#/5/\
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MC\4OZ9>B;(P>U256!P0?2K .1D5]'%GP=:%G="T4451@%%%% !1110 4444
M%>A^#](^Q:?]LE7$]P,C/\*=OSZ_E7*>&])_M75%5U)MXOGE/8CLOX_RS7I_
M2N+%5/L(VIQZA1117";!1110 48!ZBBB@!-J^@_*EHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *3 /44M% ";5_NC\J6BB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %<;XSTK#+J<2\'"3 ?H?Z?E795'/!'<V\D$R[HY%*L/:FG8
MWPU=T*BFCR&BK>I6,FFW\MK)G*'Y6Q]Y>QJI6A]9&2DE);,****!A4%W.+>
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MT+9][^T+?'U\Q:T]VK"[1.L)6/4/C_\ \R]_V\_^TJXKX38_X6;H^<=9NO\
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M=BS6EP23DGRC_A6T==3['!U858JI<JT59_LZ]_Y\[C_OTW^%']G7O_/G<?\
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M=&M-+LP1;VT812W5O4GW)R3]:OT45RMW-@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>sava-20221013.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.2.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 10/27/2022 2:59:33 PM-->
<!--Modified on: 10/27/2022 2:59:33 PM-->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" targetNamespace="http://www.cassavasciences.com/20221013" elementFormDefault="qualified" attributeFormDefault="unqualified" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:sava="http://www.cassavasciences.com/20221013" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-types="http://fasb.org/us-types/2022">
  <annotation>
    <appinfo><link:roleType roleURI="http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation"><link:definition>00090 - Document - Document And Entity Information</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="sava-20221013_lab.xml" xlink:title="Label Links, all"></link:linkbaseRef><link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="sava-20221013_pre.xml" xlink:title="Presentation Links, all"></link:linkbaseRef></appinfo></annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"></import>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"></import>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"></import>
  <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"></import>
  <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"></import></schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>sava-20221013_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.2.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 10/27/2022 2:59:33 PM-->
<!--Modified on: 10/27/2022 2:59:33 PM-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Document And Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label></labelLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>sava-20221013_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.2.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 10/27/2022 2:59:33 PM-->
<!--Modified on: 10/27/2022 2:59:33 PM-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="sava-20221013.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"></roleRef>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document And Entity Information">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638024795731540080"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType_638024795731540080" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638024795731560031"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag_638024795731560031" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638024795731570006" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName_638024795731570006" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638024795731570006" order="5" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber_638024795731570006" order="6" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638024795731570006" order="7" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638024795731570006" order="8" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2_638024795731570006" order="9" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638024795731570006" order="10" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638024795731570006" order="11" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638024795731570006" order="12" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode_638024795731570006" order="13" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber_638024795731570006" order="14" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications_638024795731570006" order="15" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial_638024795731570006" order="16" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638024795731570006" order="17" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638024795731570006" order="18" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle_638024795731570006" order="19" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol_638024795731570006" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName_638024795731570006" order="21" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638024795731570006"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638024795731570006" order="22" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638024795731579982"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638024795731579982" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140559458038592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 13, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 13,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cassava Sciences, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-29959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1911336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6801 N Capital of Texas Highway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building 1; Suite 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">501-2444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SAVA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001069530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>sava-20221013x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sava-20221013.xsd" xlink:type="simple"/>
    <context id="Duration_10_13_2022_To_10_13_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <startDate>2022-10-13</startDate>
            <endDate>2022-10-13</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-2bf1c9cf-e289-4017-a12f-218ac2648c7d">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-084f69ef-5155-4688-8ef5-0e7ddda6073b">0001069530</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-92098f62-58de-461d-8eed-356ab2b4b4d8">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-7d1eadf0-91ec-4165-a1cb-dff2c9271858">2022-10-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-a16cf31e-2476-4e50-9498-438c32fa6312">Cassava Sciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-ad8e6550-3cf9-4f72-ac32-d51f798759ac">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-888b5ebe-a911-4bc5-9ee3-f4a6dd397977">000-29959</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-0360d3a1-16e7-48a5-abb3-a0debda651d9">91-1911336</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-d0062e3f-5717-4f60-8014-fc7907f8e559">6801 N Capital of Texas Highway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-db83786a-551b-421a-af34-9aa00de6fb6f">Building 1; Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-d234f2d2-6623-4ebf-9fc3-d8626ca19e14">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-6c95a691-db9a-4408-a7b5-6040122f438b">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-9c845b64-2e42-4802-9941-2ae749577784">78731</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-ab75a49c-8bd6-4523-a8ac-09fbdf22b278">512</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-5e04066d-4666-464b-b5a7-2862990eb1cb">501-2444</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-5c2b30d5-6bd1-437d-b738-35b0dbf12b26">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-4feb3c65-ae97-48dd-a9a3-a670e525ba61">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-5cad1bda-5d40-4954-802c-d55f7ea45dfa">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-91b10ab2-476b-4803-bb40-3f180f7ff6dc">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-4317c70c-317d-4ea1-b8a8-8476edb45cc8">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-3e30f0ff-5e41-48a7-a079-f6aabf4f114a">SAVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-35ccfbc3-7354-42df-b3b2-9716bf3f798d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_10_13_2022_To_10_13_2022"
      id="ct-nonNumeric-15cd455c-da27-4757-a864-826fdd7dc075">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M-E4DYPH]&09;B(S5'WC3B?PT9>H1-N6'$2&%GN5"6&-,W&_T_$8T'D&6A^[
M](2.(2X-PW.D0XMAU]&(B^S"1I_#6(<0Y_$_,5)=8P5+J@X> @\Y1G"=P) :
M;)-6P7@H]+BB[H-5CX$E)+4* Y7L=D[E],H.KEGD7F08YRB#N+*#\%&MA1H#
MV#<YD 27Y*IU5%WI>:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$%     @
M:H!;520>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @ :H!;50=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !J@%M5;N/(
M>>T    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " !J@%M5F5R<(Q &  "<)P  $P              @ '+ 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( &J 6U5GZ.SK< 0  %\1
M   8              " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " !J@%M5GZ ;\+$"  #B#   #0              @ &R#
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &J 6U67BKL<P    !,"   +
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4!08     "0 ) #X"   3%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sava-20221013x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="sava-20221013x8k.htm">sava-20221013x8k.htm</File>
    <File>sava-20221013.xsd</File>
    <File>sava-20221013_lab.xml</File>
    <File>sava-20221013_pre.xml</File>
    <File>sava-20221013xex10_1.htm</File>
    <File>sava-20221013xex99_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sava-20221013x8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "sava-20221013x8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sava-20221013_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sava-20221013_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sava-20221013.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "sava",
   "nsuri": "http://www.cassavasciences.com/20221013",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20221013x8k.htm",
      "contextRef": "Duration_10_13_2022_To_10_13_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document And Entity Information",
     "role": "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20221013x8k.htm",
      "contextRef": "Duration_10_13_2022_To_10_13_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Document And Entity Information [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001069530-22-000051-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001069530-22-000051-xbrl.zip
M4$L#!!0    ( &J 6U6=!B9* @,  &T*   1    <V%V82TR,#(R,3 Q,RYX
M<V3-55UOVR 4?9^T_\#\/!O;4;4E<E*M[2952K:JVZ2^303C! V#!S@?_WZ
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M]T+=JNA+[B';TC#W\U#'7C]UUCO7N9)&VBN8D'W)%0]J,\;Z.7ST<1BS7'W
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M;:@\9\D>85&$PG\EEH/!.SX#QY618Q8P/!6':&4?6N0S;XD/@<_;AS=R<4I
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MIVR(7ZZJ%5S2!=,+V_BA==3"9R?I91+GW9)-3GIH^D!%,))Y7 Q%HRCYUP#
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MW0B\7'23$H'$M^&W\%Q-MWQ6>998;TF%4) H'_A_H?*$EHZ1J;*:<,5+G X
M*2=09C;"(N5CG?)Q&LTHE#@7&A!=81@W'*QL4 "(XY(1-);RR1&GM;J D:Z.
MO[S"'(EY+\Y!%55JH])416E+0<<FCM-$1@B%AKG3GG6VS9X5R(,$C6_(KOUF
M)&93Q)F!I)).Z ,@'(&AR7"I6E+:G;OQFPF9 V.A#KBBVI^T#\K82XKV;1E
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M;&Q$+*?+ULTR@,6'X0]01T(YW(<&]M;1H!!:&O0E1FQQ:C$"78F3^E5 *AJ
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M83@ZN*$"II:;&P&:MS!W^:OGW0[:2K96LFU>LHWXV..U[FO%0W\H\,Y;A-*
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MR"<LU_6'0IT<(;SNJH4XIMD:&;@[YOS)W+%%MY-_7_7AV-NJ+#C9";4.67U
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MJ<WS><QY/C"J'6ROK\+I:QQ[E,?1Z_\'4$L#!!0    ( &J 6U5<IT>M0PL
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M222,VQ$0SI%#CH]G8<72.4:0?*BQ !RX_0+:22VB!7)AAAA;F+FQ,*0II,*
M!2;CGB;*^,%)D>F>B,47JL2G1YQ[0Y(R!=A$C1;NS.V>7QTZKZKQ%@NHUAW"
M_CRVS'52J*2&HEZ=\&.\?(R77^E<O"6K/IWK7'1P* OL[:O_[TE0MY/+L1:!
MVQ'@Z.2=2/ ^G C)I(-"[]V>E/YYI?-\VV^\@&W/KS:VIFW!GU .=^\I<.-L
M[+_7Q_R'%>LMQ=8L_;L.B$!+6!P4S$W4_.J7'_SCWRM42GJY'S9_<I:^Y;39
M-9\+]9W]/7WZ]$IN[WL[TGT[''TP=+_NOAKNUU_P,GW[W/\!4$L! A0#%
M  @ :H!;59T&)DH" P  ;0H  !$              ( !     '-A=F$M,C R
M,C$P,3,N>'-D4$L! A0#%     @ :H!;538.IDOB!0  TSL  !4
M     ( !,0,  '-A=F$M,C R,C$P,3-?;&%B+GAM;%!+ 0(4 Q0    ( &J
M6U68PT]DH@0  ) J   5              "  48)  !S879A+3(P,C(Q,#$S
M7W!R92YX;6Q02P$"% ,4    " !J@%M5 W))SXD<  !/=@$ %
M    @ $;#@  <V%V82TR,#(R,3 Q,W@X:RYH=&U02P$"% ,4    " !J@%M5
M%9.'F6H<  #S)0$ &               @ '6*@  <V%V82TR,#(R,3 Q,WAE
M>#$P7S$N:'1M4$L! A0#%     @ :H!;55RG1ZU#"P  ^$X  !@
M     ( !=D<  '-A=F$M,C R,C$P,3-X97@Y.5\Q+FAT;5!+!08     !@ &
+ ),!  #O4@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
